2012 Event Partners
Sponsors
3M Drug Delivery Systems partners with pharmaceutical and biotech companies to team your molecules with our inhalation or transdermal drug delivery technology. 3M offers a full range of feasibility, development and manufacturing capabilities combined with global regulatory expertise and guidance. This depth of resources is one reason why more than 50% of all metered-dose inhalers worldwide and 80% of all transdermal systems in the U.S. utilize 3M drug delivery technology.http://www.mmm.com
Arecor has developed Arestat™, a patented technology for formulation of labile biologics as stable aqueous formulations even at high concentrations and elevated storage temperatures. A simple reformulation, Arestat™ is readily incorporated into standard manufacturing practice, without covalent modification of the biologic and using excipients approved for the route of delivery.http://www.arecor.com
Aveva Drug Delivery Systems offers a full range of Transdermal patch products for license along with a full compliment of R&D capabilities to produce transdermal drug delivery systems that fortify R&D pipelines and maximize product life cycles. Aveva is one of the world’s largest manufacturers of, and a pioneer in, transdermal drug delivery systems with a 20-year history of providing value to pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs.http://www.avevadds.com
BD Medical – Pharmaceutical Systems provides customized, clinically-proven drug delivery systems and self-injection technologies to help pharmaceutical customers’ injectable drugs reach their full potential. BD is committed to building partnerships to develop product solutions that meet evolving customer needs by leveraging innovative technologies, global manufacturing and advanced technical and scientific expertise.http://www.bd.com
BioChemics Inc., is a specialty pharmaceutical company that has developed a novel, transdermal, gel based drug delivery system for the first time that may allow almost any drug to be efficiently delivered through the skin. The transdermal technology, called Vaso-active Lipid Encapsulated (VALE®), may allow a substantial portion of the pharmacopeia to be re-engineered, turning oral drugs into transdermals that are safer (no gastro-intestinal problems), cheaper and potentially faster acting (applied directly to the treated area) than oral equivalents.http://www.biochemics.com
Catalent from drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance and provide superior, reliable manufacturing and packaging results. Catalent. More products. Better treatments. Reliably supplied.http://www.catalent.com
http://www.coriumgroup.com
http://www.flextronics.comFlextronics Medical helps pharmaceutical and medical device customers become more competitive by bringing innovative products to market faster and at lower costs through world-class integrated design, manufacturing, and logistics services with a commitment to quality and service in everything we do.
Flextroincs Medical’s end-to-end solutions are available in North America, Europe and Asia.
Building on its unique position in pain, Grünenthal’s objective is to be a leader in therapy innovation and to become the most patient-centric company. Strong research efforts are therefore dedicated to advanced and innovative drug delivery formulations. Special characteristics of Grünenthal’s new tamper resistant formulation (TRF) raise the hurdle for cutting or extracting of tablets while controlled release of the active substances is maintained.http://www.grunenthal.com
http://www.intecpharma.comIntec Pharma Ltd. (TASE: INTP), founded in 2003, has developed a patented, Gastro-retentive system (Accordion Pill®) to enhance drugs that are:
- Absorbed or act mainly in the upper GI region
- Poorly soluble.
Gastric retention is achieved under a regular calorie diet.
Intec's pipeline includes inter-alia:
1. AP-Carbidopa/Levodopa for Parkinson's disease , phase II (Israel)
2. AP-Zaleplon for Insomnia, phase II (US)
3. Programs under collaborations with global pharmaceutical companies.
http://www.ltslohmann.com/LTS Lohmann Therapie-Systeme AG is a world class developer and manufacturer of transdermal systems, oral film drug delivery systems and adhesive laminates. We use leading edge technology to manufacture developed products on a large and cost effective commercial scale. LTS develops products from inception through commercialisation in our facilities in Germany and U.S.A. under GMP conditions, both approved by the FDA and European Authorities.
LTS’ partners are many of the world’s successful pharmaceutical, consumer healthcare, medical device and diagnostic companies.
Our resources include: research & development, clinical pharmacology, technology transfer, analytical, regulatory affairs, quality assurance, operations and product support.
Medimetrics performs in-vivo trial services for drug candidate profiling, rapid formulation prototyping and monitoring GI variability. By applying IntelliCap, an intelligent electronic drug delivery capsule, typically in a pharmacokinetic study, results become clear and repeatable. IntelliCap can be employed to reduce the risk, time and cost of your development program.http://www.medimetrics.com
MedPro Safety Products is “turning prefilled upside down”. The company’s latest drug delivery device continues to protect healthcare workers through true, passive needlestick protection while making the transition to a “prefilled” device easier for pharmaceutical companies by keeping the primary container a standard drug cartridge. Every needle, every time.http://www.medprosafety.com.jpg "Novozymes")
Novozymes can not only supply our customers with unique products and technologies, but also provide dedicated R&D and regulatory support. From protein expression and cell culture to drug delivery and medical device ingredients, we have developed, safe and proven products to satisfy the needs of the future biopharmaceutical market.http://www.novozymes.com
Novaliq GmbH, Heidelberg, Germany, offers a new drug delivery technology for poorly soluble drugs, semi-fluororinated alkanes (SFA). This patented, non-aqueous and preservative-free approach offers a range of unique features and represents therefore an interesting alternative to aqueous based ophthalmic formulations. A prominent example is cyclosporine A.http://www.novaliq.de
Novartis Pharmaceuticals Corporation researches, develops, manufactures and markets leading innovative prescription drugs used to treat a number of diseases and conditions, including central nervous system disorders, organ transplantation, cardiovascular diseases, dermatological diseases, respiratory disorders, cancer and arthritis. The company's mission is to improve people's lives by pioneering novel healthcare solutions. Novartis is committed to providing access to our medications for those patients in need.http://www.novartis.com.jpg "Pacira")
Pacira Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products using its proprietary DepoFoam® sustained release injectable drug delivery technology. The potential benefits of DepoFoam have attracted partners pursuing enabling and life-cycle enhancing products for both small molecules and proteins.http://www.pacira.com
http://www.pantec-biosolutions.comInjection free intraepidermal drug delivery.
Pantec Biosolutions AG develops and commercialises a laser-powered skin microporation method (P.L.E.A.S.E.® - Painless laser epidermal system) prior to drug patch application, which extends the range of drugs that can be delivered transdermally to large molecular weight drugs. This novel application allows delivering the drugs directly into the epidermis in a dose controlled way, avoiding painful injections.
The company's first focus is to replace around hundred injections applied during hormone therapy in In Vitro Fertilisation (IVF).
Drug patch development for IVF hormones is underway, and the company will commercialise the product solution "P.L.E.A.S.E.® - device plus drug patches" with a Pharma partner company. Further interesting therapeutic areas are in preclinical development.
Q-Chip's bioresorbable microparticle-based drug delivery technology is a step-change in the development of long-acting biopharmaceutical formulations; we are tackling difficult to deliver peptides and protein therapeutics, using our disruptive, non emulsion-based Q Sphera system. We are establishing large scale aseptic production facilities for clinical trials and market entry.http://www.q-chip.com
We speak Transdermal.smhttp://www.tapemark.com
As a leading contract manufacturer, Tapemark is fluent in active and passive transdermal patches, topical patches and pads, soluble film, hydrogel, and patented unit-dose Snap!® packaging for semi-solids. Proven cGMP quality systems support Drug and Device, and Tapemark is a Schedule III – V Manufacturer of Controlled Substances.
Unilife is a U.S. based developer and manufacturer of a diversified portfolio of advanced drug delivery systems including the Unifill platform of primary containers with integrated safety. Unilife specializes in the development and commercial supply of innovative, differentiated devices that can be customized to address the specific molecular and patient requirements of a target drug. Unilife works in collaboration with its pharmaceutical and biotechnology customers during all stages of clinical development and lifecycle management to enhance and enable the commercialization of injectable drugs and vaccines including biologics.www.unilife.com.jpg "West Pharmaceutical Services")
West’s innovative system, device and component solutions help improve the safety and administration of injectable drugs. West’s proprietary materials science, formulation research and manufacturing technologies advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics and vaccines. West supports its customers from locations across the globe.http://www.westpharma.com
Zogenix introduces DosePro®, the first commercially-available, prefilled, disposable, needlefree subcutaneous delivery technology, available for licensing for injectables such as biologics. Zogenix’s first DosePro product, Sumavel®DosePro®, launched 2010, demonstrating that patients will switch from orals to injectables when available without a needle. DosePro effectively delivers small and large molecules, including MAbs.http://www.zogenix.com
Exhibitors
Battelle, the world’s largest non-profit independent research and development organization, advances scientific discovery and application by conducting $4.6 billion in global R&D annually through contract research, laboratory management and technology commercialization. Battelle manages or co-manages seven national laboratories for the U.S. Department of Energy and the U.S. Department of Homeland Security.http://www.battelle.org.jpg "Carticept Medical")
http://www.carticept.com
http://www.transdermaladhesives.comHenkel has been an integral part of the transdermal market since its inception. Our innovation and expertise have made Henkel the global leader in acrylic polymers for transdermal drug delivery. With more than 35 years' experience in acrylic pressure sensitive adhesives, expert technical service, complete regulatory support, and manufacturing capability in North America and Europe, Henkel has the experience, resources and expertise to make your transdermal project a success.
http://www.gattefosse.com
INNERCAP Technologies, Inc., a drug delivery company, offers an advanced patent pending multi-phased, multi-compartmentalized capsular-based delivery system. The system can be used to enhance the value and benefits of pharmaceutical and biopharmaceutical products. Utilizing two-piece hard shell capsules, the technology offers the industry solutions to problems affecting pharmaceutical companies, patients and healthcare providers. INNERCAP can fill a companies pipeline with a multitude of combination drug therapies.http://www.innercap.com
http://www.ligand.com.jpg "Mikron")
http://www.mikron.com/automationMikron Automation is a world leader in assembly solutions. For more than 35 years, this Swiss based company has been continuously innovating to supply the best solutions and services to major players in the Pharma/Medical industry for devices such as inhalers, pen injectors, safety syringes, lancets, pumps, diagnostic kits, confirm its expertise. The products are ISO 7 cleanroom compliant. Mikron offers a full qualification support according to GAMP-5.
Mikron Automation has facilities in Denver (USA), Boudry (Switzerland, headquarters), Singapore and Shanghai (China).
http://www.noven.com
PIERRE FABRE MEDICAMENT (Active Ingredients Division)
http://www.plantes-industrie.com
http://www.polypeptide.com
http://www.steadymed.com
Technology Catalysts International (TCI) provides consulting services that satisfy the needs of the pharmaceutical industry. We specialize in drug delivery technology licensing, assessment, and business intelligence.http://www.technology-catalysts.com
http://www.nexmedusa.com
In the field of Medical Devices teamtechnik works on high performance production systems for medical-technology components. teamtechnik is developing flexible solutions for new and innovative products, integrating sophisticated test technology.http://www.teamtechnik.com
http://www.wolfetory.com
http://www.yukonmedical.com
Media Partners
Official Media Partner: Drug Development & Delivery
Drug Development & Delivery is a print and digital publication exclusively committed to advancing the applied science, technology, and related business practices of pharmaceutical and biological drug development, including:http://www.drug-dev.com- Drug delivery technologies
- Formulation development
- Contract services
- Business development
- Life-cycle management
- Compound-enabling strategies
- Regulatory issues
- Pipeline/portfolio management
Official Online Partner: ONdrugDelivery
ONdrugDelivery is the dedicated publisher of truly specialised information on drug delivery to the global pharma, biotech, specialty pharma and drug delivery industries. ONdrugDelivery produces a highly regarded series of sponsored themed publications. Each issue focuses tighly on one topic within the field of drug delivery. Subscription to the print and pdf versions is free at: www.ondrugdelivery.comhttp://www.ondrugdelivery.com
A Portal and B2B Outsourcing Marketplace for the Biotech and Pharmaceutical Industry. The Marketplace features the Outsourcing Services Showcase; the Portal features our biopharmaceutical and venture capital directories and databases. Publications include the Bio Outsourcing Asia© Publication. Read about opportunities in India, China, Malaysia, Singapore, Taiwan and more.http://www.canbiotech.com
Combination Products Coalition
The Combination Products Coalition (CPC) is a trade association comprised of leading drug, biological product, and medical device manufacturers with substantial experience and interest in combination products (www.combinationproducts.com). Our group’s mission is to improve the regulatory environment for combination products, which we accomplish by collaboratively developing and advocating policy positions on issues affecting combination products. Our diverse, cross-industry membership brings a broad yet unified perspective on combination product issues.http://www.combinationproducts.com
http://www.currentagreements.com/
Currentpartnering is an online provider of best practice, business information and intelligence for dealmakers. Our reports cover all aspects of partnering best practice. Recent titles include: Partnering Agreements in Drug Delivery - Partnering Agreements in Diagnostics - Co-promotion and Co-marketing Agreements in Pharma and Biotech - Merger and Acquisition Agreements in Pharma and Biotech - Product and Asset Purchase Agreements in Pharma, Biotech and Diagnostics - Option and Evaluation Agreements in Pharma and Biotech - Royalty Financing Agreements in Pharma, Biotech and Diagnostics - Practical Guide to Finding Partners in Pharma and Biotech Access further details at:http://www.currentpartnering.com
Genetic Engineering and Biotechnology News
Genetic Engineering News (GEN) Now in its 27th year, Genetic Engineering & Biotechnology News (GEN) retains its position as the most widely read biotechnology publication around the globe. GEN's international purview includes applied research through commercialization. Editorial content includes regulatory, strategic alliances and collaborations, clinical trials, corporate profiles, in-depth interviews with leaders in industry, academia, and government, instructive tutorials in drug discovery and bioprocessing to enhance research results, and new products that enable significant advances in bioscience R&D. Genetic Engineering & Biotechnology News, the only high-frequency publication dedicated to biotech news, was introduced in 1981, as the first biotechnology trade publication. GEN is now the most widely read bionews publication worldwide.http://www.genengnews.com
http://www.giiresearch.com/
http://www.gobalto.com/studystartupWhat is goBalto?
goBalto is a small team that creates simple, focused software for the global drug trial industry. Our products offer drug trial sponsors the simplest possible way to start clinical studies on the web.
How we help:
We believe the existing process of starting clinical studies, are – Too complex. Too manual. Too inefficient. Whereas existing solutions focus on managing ONGOING studies, our product goes to where the problem begins – the clinical study STARTUP process. Our products want to automate and bring efficiency to the study startup process.
www.pharmalicensing.com
Innovaro Pharmalicensing is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Innovaro Pharmalicensing utilizes the unique Partnering Search service and its global network of industry experts to enable companies to identify and engage with appropriate partners around the world. Innovaro Pharmalicensing, and its sister service Innovaro Medical Device Licensing are actively utilized by over 200,000 industry professionals each month. Innovaro Pharmalicensing is part of Innovaro Inc, listed on AMEX (INV).
Inhalation is the only magazine in the world that focuses exclusively on inhaled pharmaceuticals. It serves the world pharmaceutical market and is published six times per year. For a free digital subscription go tohttp://www.inhalationmag.com
http://www.lifescienceleader.comIs your company a leader in the Life Science industry?
Life Science Leader focuses on reaching pharma and biotech executives with valuable editorial focused on how they can affect their company’s bottom line.
“I enjoyed reading through your inaugural Life Science Leader issue. I found your articles to be insightful and valuable across a range of key industry issues, and will continue to be a loyal reader.”
William S. Korinek, Ph.D., Executive Director,
Strategic Management Group, Pfizer
Through case studies, interviews, Q&A’s, and trend articles, topics covered include:
- global clinical trials
- funding
- emerging market opportunities
- drug delivery and development
Your competitors are reading Life Science Leader. Sign up for your complimentary subscription today at
http://www.luxresearchinc.com/
http://www.medtrack.comMedTRACK is the most comprehensive database of over 17,000 global private and public biomedical companies. Business development and financial professionals use MedTRACK to obtain data such as pipeline, partnering, financial and patent information on biomedical companies and products worldwide. Decision support tools such as R&D intensity, Royalty Explorer, Worldwide Patent Wizard and Management Contact searching help you sift through the data and draw conclusions quickly.
http://www.pharmacircle.com
http://www.pharmaceuticalonline.comYou’ve got a busy job, and you don’t have time to scour the internet for all the latest information on industry news and pharma suppliers. Connect with the whole industry at one location – PharmaceuticalOnline.com. Pharmaceutical Online has been serving the needs of pharmaceutical manufacturing professionals since 1997. We specialize in presenting the latest pharmaceutical innovations to a focused audience of engineering, plant management, and manufacturing professionals.
Pharmaphorum is the exciting new online discussion and networking site for the pharma, medical devices and diagnostics industry. The site features topical articles with user comments, a live forum and directories for upcoming conferences and relevant companies. With a growing audience of industry executives engaging in debate, Pharmaphorum is the place for people in healthcare to share ideas, discuss leading issues and network.http://www.pharmaphorum.com/
PharmaVOICE magazine, reaching more than 27,000 BPA audited life-sciences executives, is the forum that allows business leaders to engage in a candid dialogue on the challenges and trends impacting the industry. PharmaVOICE provides readers with insightful and thought-provoking commentary in a multiple-perspective format through forums, topics, and articles covering a range of issues from molecule through market. PharmaVOICE subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts. Additionally, pharmaVOICEMarketplace.com provides a comprehensive directory of products, services, and solutions for the life-sciences industry. To Raise Your VOICE, contact feedback@pharmavoice.com.http://www.pharmavoice.com.JPG "pharmawire")
http://www.pharmawire.comPharmawire publishes real-time news and data on the most price sensitive issues in the global pharmaceutical market. Built for financial professionals, Pharmawire covers product approvals, litigation, licensing deals and M&A. Pharmawire is a part of The Mergermarket Group, a division of the Financial Times Group, publisher of the Financial Times newspaper and FT.com. The FT Group is a division of Pearson plc, the international media group.
http://www.pharmalive.comFor more than 10 years, R&D Directions has provided the busy pharmaceutical executive with need-to-know clinical research information. Each issue delivers broad coverage and penetrating analysis of issues, events, trends, and strategies shaping drug development and pharmaceutical pipelines. Published ten times annually, R&D Directions provides exclusive content examining historical trends pertaining to and current events affecting the research of potential medicines and the companies that develop them. To learn more about R&D Directions and other products from Canon Communications Pharmaceutical Media Group visit www.pharmalive.com or call 215-944-9800.
Tablets & Capsules is the world's only magazine to exclusively focus on oral, solid dosage forms. Free subscriptions are available for North America; overseas subscriptions are only $100 for a one-year subscription.http://www.tabletscapsules.com.gif "Transdermal")
Transdermal is the only magazine in the world that focuses exclusively on delivering pharmaceuticals through the skin. It serves the world pharmaceutical market and is published six times per year. For a free digital subscription go tohttp://www.transdermalmag.com